Therapeutic efficacy of anti-MUC1 MAb (HMFG1: anti-human milk fat globules) radiolabeled with 90Y, 186Re and 131I was investigated in an OVCAR3 ovarian cancer xenograft model. Here, MUC1 is linked to ovarian carcinoma.